This programme is supported by an Independent Educational Grant from Ipsen
This programme is supported by an Independent Educational Grant from Ipsen
Merck, Novo Nordisk, Pfizer and Sandoz.
Maximising outcomes for patients with advanced neuroendocrine tumours
Learnings from clinical practice and two patient cases
Diagnosis and management of classical and non-classical forms of primary IGF-I deficiency and overlapping syndromes
Current role, potential and the example of hemophilia
Video podcast exploring primary IGF-I deficiency, GH deficiency and other rare growth disorders
Paper published in Advances in Therapy